The omega-3 supplement is preferentially standardized for EPA.
Omega-3 products manufacturer Nordic Naturals (Watsonville, CA) has introduced EPA Elite, now the company’s highest-dose of omega-3 EPA in softgels.
The product is touted as being similar to high-dose pharmaceutical EPA formulas, which have exhibited fat cell reductions (among other benefits) in clinical trials. This product, however, is available over-the-counter.
While fish oil supplements are traditionally standardized for omega-3 EPA and omega-3 DHA, Nordic Naturals says that significant research supports EPA-only formulas for heart health factors specifically. At 1600 mg of omega-3 EPA per serving, EPA Elite is more concentrated than the company’s EPA Xtra product, which contains 1060 mg of the essential fatty acid.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.